Product Introduction:
Cyra-LS 75/20 mg Tablet is a fixed-dose combination containing Levosulpiride (75 mg) and Rabeprazole (20 mg). Levosulpiride is a prokinetic agent that improves gut motility, while Rabeprazole is a proton pump inhibitor (PPI) that reduces stomach acid. This combination is commonly prescribed for GERD, functional dyspepsia, acid reflux, and related gastrointestinal issues.
Uses:
-
Gastroesophageal reflux disease (GERD)
-
Functional dyspepsia
-
Indigestion and bloating
-
Acid reflux and heartburn
-
Prevention of ulcers caused by excess acid
Benefits:
-
Rapid and long-lasting relief from acidity and heartburn
-
Promotes gastric emptying and gut movement
-
Reduces bloating and abdominal discomfort
-
Treats acid-related stomach and intestinal issues
Composition (per tablet):
-
Levosulpiride 75 mg (sustained-release)
-
Rabeprazole 20 mg (enteric-coated)
Side Effects:
-
Nausea, dizziness
-
Constipation or diarrhea
-
Headache
-
Drowsiness or fatigue
-
Long-term use may affect calcium, magnesium, or B12 levels
Safety Advice:
-
Take before meals for better effectiveness
-
Swallow whole; do not crush or chew the tablet
-
Use under medical supervision, especially in long-term therapy
-
Avoid alcohol and smoking to enhance treatment efficacy
-
Store in a cool, dry place away from moisture
-
Not recommended in children without doctor’s advice
